Dot blot assay showed that METTL14 was essential for m6A modification since the overall m6A level dramatically declined upon METTL14 silence in ESCC (Fig. 7f and Supplementary Fig. 7d). The gene discussed is METTL14; the disease is esophageal squamous cell carcinoma.